FFF Enterprises Celebrates its 25th Anniversary with a Track Record of Safety and Innovation

Press Release for July 09, 2013 - Download

Temecula, Calif – FFF Enterprises, Inc., the nation’s largest and most trusted distributor of plasma products, vaccines and critical-care biopharmaceuticals celebrated its 25th anniversary on July 8, 2013. With a focus on safety and innovation, the company begins its 26th counterfeit-free year with a proactive approach to helping its customers - both healthcare providers and their patients - navigate the dynamic and changing healthcare landscape.

“The only thing that has been predictable in our company’s history has been the unpredictability of the biopharmaceutical marketplace,” says Patrick M. Schmidt, chief executive officer, FFF Enterprises, Inc. “Our goal has always been to get the critical-care products we distribute from the manufacturer to the patient in the most efficient, streamlined way possible, minimizing the complexity for our customers and maximizing patient safety.” In 2013, FFF began exploring improved methods for inventory storage and management by investing in the Verified Inventory Program-Consignment (VIPc)™ that employs passive radio frequency identification (RFID) technology. This new program will augment the company’s current method of monitoring products that pass through its care by remotely tracking, managing and replenishing critical product inventory in real-time, as it is used by customers, as well as monitor storage temperatures and expiration dates. Verified offers yet another level of verification to FFF’s secure channel, and reinforces the company’s commitment to product efficacy and patient safety.

“This solution not only allows us to identify the products that are critical to our customers, but more importantly we can make sure the products they need are there when their patients need them most,” says Chris Ground, chief operating officer. “This technology complements our hands-on service by allowing those on the front lines to focus more on their patients and worry less about their inventory.” The Verified system highlights FFF’s ongoing efforts to improve product distribution technology and create an even more secure supply chain.

FFF Enterprises was founded in 1988 with $100 and a vision to distribute patient examination gloves. Today, the company's annual sales approach $1 billion, and its partners include the largest and most influential GPOs, serving over 80 percent of U.S. hospitals and supplying the nation's leading non-acute care sites. Almost from the start, FFF set out to reshape the biopharmaceutical industry by making the supply chain safer for patients. FFF's mission, “Helping Healthcare Care,” is epitomized by other innovative technologies such as its Verified Electronic Pedigree (VEP) system, which electronically displays the chain of custody for every product it ships, and its Lot-Track service, which tracks products by lot number and provides recall notification to those affected. The company’s foresight also led to the development of a best practices business model dubbed “The 8 Critical Steps to Guaranteed Channel Integrity.”

FFF's patient-centered focus resonates through its specialty pharmacy subsidiary, NuFACTOR, which provides immune globulin, coagulation factors and vaccines directly to patients. Other innovative programs include MyFluVaccine and VaxAmerica, which provide revolutionary approaches to vaccine access and administration.

 “We believe our industry is in a pivotal time of growth, and as a result, we are looking at various business models and innovations to help clarify the issues facing all stakeholders in the healthcare equation, and do our part to offer solutions,” explains Schmidt. “Our interactions with patients, providers and payers are evolving as we strive to best meet the changing needs of this dynamic industry.”

About FFF Enterprises, Inc.
Temecula-based FFF Enterprises is the largest and most trusted distributor of plasma products, vaccines and other biopharmaceuticals in the U.S. Founded in 1988, FFF is now in its 26th year with nearly a billion dollars in annual sales and a flawless safety track record. FFF has taken a leadership position in regards to supply chain safety and innovation, setting new standards and pioneering industry firsts. FFF's commitment to Guaranteed Channel Integrity™ ensures that products are purchased only from the manufacturer and shipped only to healthcare providers, with additional steps taken to safely store, handle and ship products to ensure patient safety is never compromised. FFF's proprietary systems, Verified Electronic Pedigree™ and Lot-Track™, provide verification of this secure channel, and FFF's MyFluVaccine.com and VaxAmerica.com (www.VaxAmerica.com) are revolutionary vaccination programs that have added a new level of safety, convenience and reliability to both healthcare providers and consumers

Cheryl Brooks, VP of Marketing and Communications
(951) 296-2500, ext. 1177